|
gptkbp:instanceOf
|
gptkb:chemical_compound_series
|
|
gptkbp:actsOn
|
5-HT2A receptor
|
|
gptkbp:alsoKnownAs
|
25-NBOMe series
|
|
gptkbp:category
|
psychedelic phenethylamines
designer drugs
serotonin receptor agonists
|
|
gptkbp:consequence
|
confusion
hypertension
seizures
tachycardia
hallucinations
agitation
death (in overdose)
vasoconstriction
|
|
gptkbp:discoveredBy
|
gptkb:Ralf_Heim
|
|
gptkbp:firstReported
|
scientific literature
|
|
gptkbp:firstSynthesized
|
2003
|
|
gptkbp:legalStatus
|
varies by country
|
|
gptkbp:marketedAs
|
research chemical
|
|
gptkbp:notableMember
|
gptkb:25B-NBOMe
gptkb:25C-NBOMe
gptkb:25D-NBOMe
gptkb:25E-NBOMe
gptkb:25H-NBOMe
gptkb:25I-NBOMe
gptkb:25N-NBOMe
gptkb:25P-NBOMe
gptkb:25TFM-NBOMe
gptkb:NBOMe-mescaline
|
|
gptkbp:parent
|
gptkb:2C-E
gptkb:2C-B
gptkb:2C-C
gptkb:2C-D
gptkb:2C-H
gptkb:2C-I
gptkb:2C-N
gptkb:2C-P
gptkb:2C-TFM
mescaline
|
|
gptkbp:relatedTo
|
gptkb:amphetamine
2C series
|
|
gptkbp:riskFactor
|
risk of overdose
high toxicity
|
|
gptkbp:routeOfAdministration
|
insufflation
sublingual
buccal
|
|
gptkbp:structure
|
N-benzyl substitution
methoxy groups
|
|
gptkbp:usedAs
|
psychedelic
|
|
gptkbp:bfsParent
|
gptkb:NBOH
gptkb:ST-18
|
|
gptkbp:bfsLayer
|
6
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
NBOMe series
|